
OMI
USDOwens & Minor Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$7.050
Máximo
$7.510
Mínimo
$6.980
Volume
0.16M
Fundamentos da empresa
Capitalização de mercado
580.2M
Setor
Medical Distribution
País
United States
Estatísticas de negociação
Volume médio
1.88M
Bolsa de valores
NYQ
Moeda
USD
Faixa de 52 semanas
Relatório de análise de IA
Última atualização: 2/05/2025OMI: Owens & Minor Inc. Common Stock - What's Happening and What to Watch
Stock Symbol: OMI Generate Date: 2025-05-02 18:09:33
Alright, let's break down what's been going on with Owens & Minor (OMI) based on the latest info we've got. Think of this as getting the lowdown on a company's recent activity and what might be coming next.
The Latest Buzz (News Sentiment)
So, what's the general feeling around OMI right now? It's a bit of a mixed bag, honestly.
First off, we know the company is getting ready to spill the beans on its first-quarter 2025 earnings. They've set the date for May 8th, right before the market opens. This isn't good or bad news by itself, but it's a really important date to circle on the calendar. Earnings reports can often cause the stock price to jump or drop depending on how the company did.
Then there's the word from Citigroup. An analyst there, Daniel Grosslight, still thinks OMI is a "Buy." That's a positive sign – someone who studies this stuff thinks the stock is worth owning. But, and this is the twist, they lowered their price target. It went from $13 down to $11. So, while they still like the stock, they don't see it going quite as high as they did before.
Putting it together, the news vibe is cautiously optimistic. An analyst likes the stock, which is good, but the reduced price target adds a note of caution. And everyone's waiting for those earnings results next week.
Checking the Price Tag (Price Action)
Now, let's look at what the stock price itself has been doing over the past little while. Looking back about three months, OMI's price has taken quite a tumble. It started near $13 back in early February and slid pretty steadily down into the $6-$7 range by mid-April. That's a significant drop.
More recently, over the last couple of weeks, the price seems to have settled into a bit of a range, bouncing around between roughly $6.50 and $7.50. It's been a bit choppy in there. As of today, May 2nd, the price is sitting around the $7.34 mark (based on the last recorded close).
What about where it might go next? An AI prediction model is suggesting small positive moves for the next few days – a tiny bump today, then slightly bigger increases tomorrow and the day after. This hints that the recent stabilization might continue with a slight upward lean in the very short term.
What This Might Mean & Some Ideas (Outlook & Strategy)
Okay, let's try to connect the dots from the news, the price chart, and the AI's short-term guess.
Given the recent price drop followed by stabilization, the analyst still saying "Buy" (even with a lower target), and the AI predicting a small near-term uptick, the situation might suggest a cautiously positive leaning from the current price level, at least in the immediate future leading up to earnings.
The company's profile shows it's in the Medical Distribution business, providing essential supplies. This sector can be stable, but things like healthcare spending trends and supply chain issues can definitely affect it. It's also a relatively smaller company with a market cap around $567 million, which can sometimes mean bigger price swings. The data also points out a low P/E ratio (around 3.9x compared to an industry average of 5.7x), which often flags a stock as potentially undervalued. However, it also flags significant debt and negative return on equity, which are important fundamental risks to be aware of.
One analysis suggests potential entry points around $6.96 or $7.02. The current price is a bit above that. The AI prediction, though, is based on the current level and sees slight upward movement from here. So, someone looking at this might consider if the current price area makes sense for them, keeping in mind the AI's short-term view.
For managing risk, the same analysis suggests a potential stop-loss level around $6.25. This is below the recent trading range and could be a point to consider exiting if the price starts falling significantly again. It also mentions a potential take-profit level of $7.08, which is actually below the current price – that specific level might be less relevant now given where the stock is trading, but it highlights that potential immediate upside might be seen as limited by some analyses.
The biggest thing on the horizon is that May 8th earnings report. That event has the potential to completely change the picture, either confirming a positive trend or sending the stock lower if results disappoint.
Here's the takeaway: OMI has been beaten down but seems to be finding its feet lately. An analyst still likes it, and AI sees a small positive move coming. There are fundamental reasons it looks cheap (low PE), but also significant risks (debt, profitability). The upcoming earnings are the main event to watch, as they'll likely dictate the next big move.
Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research or consult with a qualified financial advisor before making any investment decisions.
Notícias relacionadas
Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call
Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the first quarter of 2025 on Thursday, May 8, 2025, before trading begins on the New York Stock Exchange. The Company will host a conference
Citigroup Maintains Buy on Owens & Minor, Lowers Price Target to $11
Citigroup analyst Daniel Grosslight maintains Owens & Minor with a Buy and lowers the price target from $13 to $11.
Previsão de IABeta
Recomendação de IA
Atualizado em: 3/05/2025, 19:20
63.0% Confiança
Risco e negociação
Ponto de entrada
$7.41
Tomar lucro
$8.13
Parar perda
$6.76
Fatores-chave
Ações relacionadas

GJS
Goldman Sachs Group Securities STRATS Trust for Goldman Sachs Group Securities Series 2006-2

IVA
Inventiva S.A. American Depository Shares

MA
Mastercard Incorporated

SHO
Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc. Common Shares

ZBH
Zimmer Biomet Holdings Inc.
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.